These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11214187)

  • 1. Optimizing clinical outcomes by the use of pharmokinetic and pharmacodynamic principles.
    Quintiliani R
    J Med Liban; 2000; 48(4):182-5. PubMed ID: 11214187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic factors of antibiotic efficacy.
    Rotschafer JC; Zabinski RA; Walker KJ
    Pharmacotherapy; 1992; 12(6 Pt 2):64S-70S. PubMed ID: 1480502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance--what's dosing got to do with it?
    Roberts JA; Kruger P; Paterson DL; Lipman J
    Crit Care Med; 2008 Aug; 36(8):2433-40. PubMed ID: 18596628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic considerations for the selection of oral cephalosporins in the treatment of rhinosinusitis.
    Dandekar PK; Nicolau DP
    Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S10-6. PubMed ID: 12511855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.
    Owens RC; Ambrose PG
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):77S-83S. PubMed ID: 17292579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease.
    Eyler RF; Mueller BA
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):392-403. PubMed ID: 20727509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics/Pharmacodynamics for critical care clinicians.
    Quintiliani R; Quintiliani R
    Crit Care Clin; 2008 Apr; 24(2):335-48, xi. PubMed ID: 18361949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.
    Lodise TP; Lomaestro BM; Drusano GL;
    Pharmacotherapy; 2006 Sep; 26(9):1320-32. PubMed ID: 16945055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial pharmacodynamics.
    Ambrose PG; Owens RC; Grasela D
    Med Clin North Am; 2000 Nov; 84(6):1431-46. PubMed ID: 11155851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents.
    Schuck EL; Derendorf H
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):361-73. PubMed ID: 15954853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.